Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEMAZEPAM Cause Electrocardiogram qrs complex prolonged? 15 Reports in FDA Database

Wake Up Pain-Free — Sleep Like Never Before

Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.

Shop Now — 75% Off

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Electrocardiogram qrs complex prolonged have been filed in association with TEMAZEPAM (Temazepam). This represents 0.3% of all adverse event reports for TEMAZEPAM.

15
Reports of Electrocardiogram qrs complex prolonged with TEMAZEPAM
0.3%
of all TEMAZEPAM reports
3
Deaths
13
Hospitalizations

How Dangerous Is Electrocardiogram qrs complex prolonged From TEMAZEPAM?

Of the 15 reports, 3 (20.0%) resulted in death, 13 (86.7%) required hospitalization, and 9 (60.0%) were considered life-threatening.

Is Electrocardiogram qrs complex prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEMAZEPAM. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does TEMAZEPAM Cause?

Toxicity to various agents (1,583) Completed suicide (840) Overdose (759) Drug ineffective (733) Drug abuse (626) Pain (558) Headache (544) Off label use (534) Hyperhidrosis (486) Hypersensitivity (479)

What Other Drugs Cause Electrocardiogram qrs complex prolonged?

BUPROPION (604) FLECAINIDE (324) AMITRIPTYLINE (289) LAMOTRIGINE (256) QUETIAPINE (217) LOPERAMIDE (209) VENLAFAXINE (175) ESCITALOPRAM OXALATE (148) AMLODIPINE (145) PROPRANOLOL (133)

Which TEMAZEPAM Alternatives Have Lower Electrocardiogram qrs complex prolonged Risk?

TEMAZEPAM vs TEMODAR TEMAZEPAM vs TEMOZOLOMIDE TEMAZEPAM vs TEMSIROLIMUS TEMAZEPAM vs TENAMFETAMINE TEMAZEPAM vs TENAPANOR

Related Pages

TEMAZEPAM Full Profile All Electrocardiogram qrs complex prolonged Reports All Drugs Causing Electrocardiogram qrs complex prolonged TEMAZEPAM Demographics